Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine. - de Cássia Collaço R; Lammens M; Blevins C; Rodgers K; Gurau A; Yamauchi S; Kim C; Forrester J; Liu E; Ha J; Mei Y; Boehm C; et al. (Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2024)